Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-27 GOLDBERG MORTON Director Exercise or conversion +1,083 $1.70 $2K 18,360
2017-02-27 GOLDBERG MORTON Director Exercise or conversion · Stock Option (right to buy) −1,083 1,917
2017-02-06 Romano Sarah Interim CFO Grant or award +2,500 2,500
2017-02-06 Mann Brenda VP of Research & Development Grant or award +2,500 11,751
2017-02-06 MANZO MICHAEL P. Vice President of Engineering Grant or award · Stock Option (right to buy) +15,000 15,000
2017-02-06 Wirostko Barbara Chief Medical Officer Grant or award +15,000 154,942
2017-02-06 FROM STEPHEN President and CEO Grant or award +60,000 199,965
2016-09-15 FROM STEPHEN President and CEO Purchase +15,000 $1.49 $22K 139,965

Page 24 of 24 · 468 trades